26 Jan CDC publication acknowledges Aegis Sciences and Walgreens for their work
The Centers for Disease Control publishes two Morbidity and Mortality Weekly Reports utilizing spike-protein target failure/performance, SGTF/rSGTP, as a proxy...
The Centers for Disease Control publishes two Morbidity and Mortality Weekly Reports utilizing spike-protein target failure/performance, SGTF/rSGTP, as a proxy...
NASHVILLE, Tenn. (Jan. 23, 2023) – Aegis Sciences Corporation, a health care testing lab based in Nashville, has published a Journal of...
Acquisition enhances Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing NASHVILLE, TN, January 16, 2023 – Aegis...
In collaboration with Walgreens, data analysis examines more than 300,000 COVID-19 samples during Omicron surge NASHVILLE, Tenn., (Oct. 6, 2022) – A...
Industry-leading testing offers insight into drug patterns and facilitates informed care Aegis Sciences Corporation, today announced the expansion of their proprietary, industry-leading...
Authorized by the CDC as one of five commercial labs to perform these tests nationwide NASHVILLE, Tenn. (July 14, 2022) – Aegis Sciences...